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Addiction to Cocaine Minireview
and Amphetamine
Steven E. Hyman* but not DA reuptake, produce neither significant rein-
forcement in animal models nor euphoria in humans.Laboratory of Molecular and Developmental
Neuroscience Moreover, antidepressants do not produce dependence
in humans even with very long-term use. In addition,Massachusetts General Hospital
Harvard Medical School lesioning of DA terminals within the NAc or full pharma-
cological blockade of DA receptors inhibits cocaine orBoston, Massachusetts 02114
amphetamine self-administration (reviewed by Self and
Nestler, 1995). It is also significant that mice lacking theAddiction to the psychostimulant drugs, of which co-
DAT are entirely insensitive to the locomotor stimulantcaine and the amphetamine derivatives are the most
effects of cocaine or amphetamine (Giros et al., 1996).important, is one of the foremost public health problems
The precise contributions of different postsynaptic DAin the United States. Cocaine and amphetamine share
receptors to reinforcement have yet to be fully estab-two critical properties with other addictive drugs: they
lished because of the lack of adequately selective antag-are reinforcing when administered acutely (i.e., drug use
onists directed against the five known DA receptors.entails repeated drug use) and produce compulsive use
Studies of drug self-administration in mice with disrup-if administered chronically with adequate dose and fre-
tions in the genes encoding each of the different DAquency.
receptors as well as the DAT may also prove informative;The mesoaccumbens dopamine (DA) pathway, ex-
however, the difficulty of establishing drug self-adminis-tending from the ventral tegmental area (VTA) of the
tration in the mouse strains currently used for homolo-midbrain to the nucleus accumbens (NAc; the major
gous recombination and the problem of developmentalcomponent of the ventral striatum), has been identified
compensation has slowed this type of analysis. Basedas the critical shared substrate of the reinforcing effects
on pharmacological data available to date, both D1 fam-of cocaine, amphetamine, and all other addictive drugs
ily and D2 family DA receptors contribute to cocaine(Koob, 1996 [this issue of Neuron]). Drugs such as co-
and amphetamine reinforcement (reviewed by Self andcaine and amphetamine are thought to be addictive
Nestler, 1995), although it is the D1 receptor that hasbecause they produce significant molecular adaptations
been implicated in cocaine- and amphetamine-inducedboth within and outside the mesoaccumbens circuitry
plasticity to date.that alter the function of neurons that regulate motivated
Addiction to Cocaine and Amphetaminebehavior and emotion. Progress has been made in iden-
The acute reinforcing effects of cocaine and amphet-tifying both the properties of drugs that make them rein-
amine lead to patterns of drug use that, in epigeneticallyforcing and the potentially relevant adaptations within
vulnerable individuals, result eventually in addiction, athe VTA and in dopaminergically innervated brain re-
state hypothesized to be the result of plastic changesgions including both the NAc and dorsal striatum.
in multiple neural circuits. The types of plasticity thatAcute Actions of Cocaine and Amphetamine
underlie addiction can be divided conceptually intoThe critical mechanism by which cocaine and amphet-
three groups: compensatory adaptations in neural sys-amine produce reinforcement is their ability to increase
tems that regulate autonomic and other somatic func-synaptic DA levels in the mesoaccumbens circuit. Co-
tions leading to physical dependence and withdrawal;caine blocks the DA reuptake transporter (DAT), a mem-
adaptations in the mesoaccumbens brain reward cir-ber of the Na1/Cl2-dependent twelve transmembrane
cuitry itself resulting in the emotional and motivationaldomain transporter family that also includes the norepi-
aspects of dependence and withdrawal; plasticity in-nephrine and serotonin transporters. Amphetamine has
volving both the mesoaccumbens circuitry and othermore complex actions, but its most significant effect is
limbic circuits yielding sensitization and cue-dependent,to cause reverse transport of DA via the DAT. In mice
positively biased emotional memories of drug use thatlacking a DAT, as a result of targeted gene disruption,
may predispose to relapse. Unlike the opiates and etha-amphetamine does not increase synaptic DA levels
nol, cocaine and amphetamine do not produce physical(Giros et al., 1996).
dependence; they are nonetheless among the most rein-There are significant homologies within the Na1/Cl2-
forcing and addictive drugs known, underscoring thedependent transporter family; thus, cocaine and am-
importance of plasticity in emotional circuits.phetamine also increase synaptic levels of norepineph-
With cocaine and amphetamine, tolerance to the rein-rine and serotonin. While these other monoamine neu-
forcing effects may be marked, leading toadministrationrotransmitters may contribute to the reinforcing or
of very high drug doses. Compared with amphetamine,addictive (i.e., plasticity-inducing) effects of cocaine and
cocaine has a very short duration of action that leadsamphetamine, it is the increase in synaptic DA that is
to a typical pattern of administration: rats or humansnecessary for and central to reinforcement. Antidepres-
given access to adequate supplies of cocaine oftensant drugs that block norepinephrine and/or serotonin,
binge, i.e., self-administer multiple closely spaced
doses over long periods of time. Abstinence following
such a binge may dramatically unmask neural adapta-*Present address: Office of the Director, National Institute of Mental
Health, National Institutes of Health, Rockville, Maryland 20857. tions that have occurred, as evidenced by a withdrawal
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syndrome in humans of dysphoria, anhedonia, and drug sensitization to cocaine has been reported to persist
for a month after withdrawal and is correlated with ancraving with eventual reinstatement of drug use. Anhe-
donia in humans may be modeled in rats by transient enhancement of D1 DA receptor responses in the NAc
(Henry and White, 1995). D1 receptors are expressed indecreases in DA neurotransmission and elevations in
electrical brain self-stimulation reward thresholds ob- the NAc and in the dorsal striatum, predominantly on
striatonigral neurons, which are GABAergic and alsoserved after cocaine administration (Markou and Koob,
1991). synthesize the neuropeptide precursors prodynorphin
and preprotachykinin. Since no consistent changesPharmacological attempts to inhibit the reinstatement
of cocaine or amphetamine self-administration after dis- have been observed in D1 receptor number or affinity
after chronic cocaine administration, supersensitive D1continuation have utilized both DA receptor antagonists,
aimed at blocking subsequent reinforcement, or DA re- responses likely reflect changes in postreceptor signal
transduction. Since D1 receptors are positively linkedceptoragonists, aimed either at supplementingtransient
decreases in dopaminergic neurotransmission during to the adenylyl cyclase via Gs and Golf, it is significant
that chronic cocaine administration increases levels ofwithdrawal, or decreasing the likelihood of subsequent
cue-dependent drug craving. Current DA receptor an- adenylyl cyclase and cAMP-dependent protein kinase
in the NAc, while decreasing levels of Gia (reviewed bytagonists are unacceptable treatments because they
exacerbate anhedonia and dysphoria and because D2 Self and Nestler, 1995).
Cocaine- and Amphetamine-Regulatedreceptor antagonists cause serious motor side effects.
Selective D2 agonists such as bromocriptine have been Gene Expression
Cocaine and amphetamine have potent effects on pro-used to treat craving in humans without great success.
Strikingly, in a rat model in which cocaine self-adminis- tein phosphorylation and gene regulation in dopamino-
ceptive neurons in the dorsal striatum and the NAc. Antration was extinguished by replacement of cocaine with
saline, D2 agonists caused reinstatement of self-admin- ongoing challenge is to relate these effects to electro-
physiological and behavioral observations. Acute ad-istration, possibly as an interoceptive cue, whereas a
D1 agonist did not. In addition, a D1 agonist prevented ministration of amphetamine and cocaine induce cAMP
response element±binding protein (CREB) phosphoryla-reinstatement of self-administrationcaused by a priming
dose of cocaine itself (Self et al., 1996). tion (Konradi et al., 1994) and expression of both AP-1
(e.g., c-fos, fras, and junB) and non-AP-1 family immedi-While a subset of adaptations to cocaine and amphet-
amine produce tolerance and dependence (and there- ate early genes (IEGs) in both the dorsal and ventral
striatum (Self and Nestler, 1995). In addition, both am-fore upon drug cessation, withdrawal), other drug-in-
duced adaptations produce sensitization, i.e., a subset phetamine and cocaine have been shown to induce
AP-1 binding activity in striatal cell extracts (Nguyen etof drug effects increase with repeated use. In humans,
some aspects of sensitization may increase craving for al., 1992; Hope et al., 1992).
As described, D1 DA receptor signaling has been im-drugs even if, as a result of tolerance, the actual enjoy-
ment of drugs is diminished (Robinson and Berridge, plicated in sensitization; it appears to play an obligate
role in cocaine- and amphetamine-induced gene ex-1993). Another form of sensitization observed in humans
is a syndrome of cocaine- or amphetamine-induced pression. Psychostimulant-induced CREBphosphoryla-
tion and IEG expression are both blocked by D1 recep-paranoia, which, once initiated, may be reinstated even
with relatively low drug doses after prolonged absti- tor antagonists (Konradi et al., 1994, and references
therein). Consistent with this pharmacological finding,nence.
In animal models, behavioral sensitization is generally double label in situ hybridization studies demonstrate
that cocaine (Kosofsky et al., 1995) and amphetaminestudied by observingan increase in the locomotor stimu-
latory effects or stereotyped behaviors produced by co- (Jaber et al., 1995) induce IEG expression primarily in
striatonigral neurons.caine and amphetamine. Tolerance, dependence, or
sensitization is differentially most strongly elicited with Induction of CREB phosphorylation and expression
of IEG transcription factors by acute cocaine and am-different drug administration paradigms and different
timepoints after the final dose. Differences in these pa- phetamine have been hypothesized to initiate down-
stream molecular events, which in the longer term couldrameters likely explain many inconsistencies in behav-
ioral and physiological findings of different labs. Toler- exert significant behavioral consequences. Potential
targets of cocaine- and amphetamine-induced tran-ance, dependence (with subsequent withdrawal), and
sensitization are likely all experienced by drug addicted scriptional activators include the neuropeptide genes
expressed within D1 receptor expressing neurons. In-humans and contribute to compulsive drug use.
Adaptations Correlated with Sensitization deed, cocaine and amphetamine have been shown to
induce expression of preprotachykinin mRNA and ofThe VTA appears to be required for initiation of locomo-
tor sensitization; however, the NAc is required for its prodynorphin mRNA and peptides in striatonigral neu-
rons (Jaber et al., 1995, and references therein). Prody-expression (see references in Self and Nestler, 1995).
Changes in the mesoaccumbens circuitry that would norphin gene expression has also been shown to be
induced in other states of putative DA excess, eitherincrease theeffects of DA and might thereforecontribute
to sensitization include augmentation of the ability of due to the lossof functional DAT in knockout mice (Giros
et al., 1996) or following administration of D1 receptorcocaine or amphetamine to increase extracellular DA
concentrations in the NAc, decreased sensitivity of DA agonists in rats with a 6-hydroxydopamine lesion sub-
stantia nigra (Steiner and Gerfen, 1995, and referencesautoreceptors (presynaptic D2 receptors), and super-
sensitivity of postsynaptic D1 receptors. Locomotor therein). In contrast, mice lacking D1 receptors as a
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Figure 1. Potential Role for Prodynorphin Induction as a Compensa-
tory Adaptation to Cocaine and Amphetamine
Projection neurons in the NAc and dorsal striatum also have recur-
rent collateral axons. A subset of these neurons express D1 DA
receptors and the prodynorphin gene, expression of which is in-
duced by excess DA stimulation produced by cocaine and amphet-
amine. The release of dynorphin, via recurrent collaterals, on the
presynaptic terminals of DA neurons acts via inhibitory k opioid
receptors to decrease DA release, thus acting as a compensatory
ªbrakeº on further DA release.
result of targeted gene disruption exhibit decreased pro-
dynorphin gene expression (Xu et al., 1994).
Figure 2. Schematic Representation of Transcriptional RegulationThe regulation of the prodynorphin gene by cocaine
Mediated via the D1 DA Receptor and NMDA Glutamate Receptor
and amphetamine could be a biologically significant Pathways
adaptive mechanism contributing to the motivational
Cocaine- and amphetamine-regulated gene expression in the dorsal
aspects of withdrawal. Dynorphin peptides can signal and ventral striatum is inhibited by D1 or NMDA receptor antago-
back on presynaptic DA terminals within the striatum nists. Shown in the lower half of the figure is a composite promoter
with a consensus AP-1 site and CRE. D1 receptor stimulation of thevia recurrent axon collaterals (Figure 1). Acting via k
cAMP pathway leads to CREB phosphorylation that has been linkedopiate receptors on DA terminals, dynorphin peptides
to induction of both the c-fos and prodynorphin genes in striatalappear to decrease DA release (Steiner and Gerfen,
neurons. Activation of calmodulin-dependent protein kinases also
1995). k receptor agonists produce an aversive dys- leads to CREB phosphorylation, although this has not been investi-
phoric syndrome in drug naive humans and rats. Thus, gated directly in striatal neurons. The downstream actions of NMDA
an increase in dynorphin peptides following chronic psy- receptor stimulation in these dopaminoceptive neurons on both
AP-1 and CREB-mediated transcription, including the role, if any ofchostimulantadministration maybe a compensatory ad-
MAP kinase cascades, remains unsettled.aptation to excess DA stimulation that, by inhibiting the
release of DA, may contribute to the dysphoric state that
occurs with drug cessation and therefore to withdrawal.
The prodynorphin gene contains three cAMP re- and amphetamine-induced plasticity (subserving a type
of implicit memory), as well as in other types of memorysponse elements (CREs) in its 59 flanking region. In pri-
mary striatal cultures, induction of prodynorphin gene functions.
Cocaine- and amphetamine-induced gene regulationexpression by DA has been shown to be dependent on
D1 receptor stimulation and to correlate with Ser-133 is more complex, however, with increasing evidence
that the D1 DA receptor pathway interacts significantlyphosphorylation of CREB (Cole et al., 1995). CREB has
been shown to be phosphorylated on its critical Ser- with N-methyl-D-aspartic acid (NMDA) glutamate recep-
tor pathways (Figure 2). It has been demonstrated by133 in vivo in response to amphetamine (Konradi et
al., 1994); with chronic amphetamine administration, the several groups that cocaine- and amphetamine-induced
IEG expression is inhibited by NMDA receptor antago-time course of CREB phosphorylation is markedly pro-
longed (Cole et al., 1995), consistent with up-regulation nists in vivo. Moreover, behavioral sensitization and D1
receptor supersensitivity are also prevented if MK-801of other components of the cAMP system (described
above) by chronic cocaine (Self and Nestler, 1995). The is coadministered with amphetamine (Wolf et al., 1994).
Explanations for the effects of MK-801 have largely fo-D1 receptor±cAMP±CREB pathway (Figure 2) may serve
as an important mechanism of adaptation, contributing cused on neural circuit interactions. NMDA receptor
blockade has been hypothesized to inhibit the releasenot only to prodynorphin gene regulation, but also to
regulation of many additional target genes that contain of DA within the striatum or to inhibit DA D1 receptor
function. However, NMDA receptor±activated intracellu-CREs. The posited role for CREB in plasticity produced
by drugs of abuse has a parallel in recent work implicat- lar Ca21 pathways may also play a critical role in D1
receptor±mediated gene expression and deserve furthering CREBin some forms of long-term synaptic plasticity,
including a role in the maintenance phase of long-term investigation. CREB has been shown to be a substrate
not only for the cAMP-dependent protein kinase, butpotentiation (LTP) and in models of learning in Aplysia,
Drosophila, and mice (reviewed by Carew, 1996). Both also for several Ca21/calmodulin protein kinases; in addi-
tion, NMDA receptors may activate additional signalingLTP and LTD have been demonstrated in the NAc (Kom-
bian and Malenka, 1994), although the molecular corre- pathways within neurons such as MAP kinases.
Potential Functional Roles of AP-1 Proteinslates in the NAc have not yet been identified. While there
is a long way to go in dissecting the role of CREB in in Adaptations to Psychostimulants
Unlike CREB, which is constitutively synthesized anddifferent types of long-term behavioral change, it ap-
pears to be a critical molecular switch in both cocaine- regulated largely by protein phosphorylation, proteins
Neuron
904
Selected Readingof the Fos family are induced from very low levels of
expression by acute cocaine or amphetamine adminis- Brown, E.E., Robertson, G.S., and Fibiger, H.C. (1992). J. Neurosci.
tration. With repeated stimulation, induction of c-fos, 12, 4112±4121.
c-jun, junB, and zif/268 is markedly down-regulated Carew, T.J. (1996). Neuron 16, 5±8.
(Hope et al., 1992). In contrast, certain Fos-related anti- Cole, R.L., Konradi, C., Douglass, J., and Hyman, S.E. (1995). Neuron
gens accumulate with chronic cocaine treatment or 14, 813±823.
other chronic stimuli (ªchronic Frasº) and are expressed Giros, B., Jaber, M., Jones, S.R., Wightman, R.M., and Caron, M.G.
(1996). Nature 379, 606±612.persistently (Hope et al., 1994). Alterations in the compo-
Hope, B.T., Kosofsky, B., Hyman, S.E., and Nestler, E.J. (1992). Proc.sition of AP-1 complexes over time might permit cells
Natl. Acad. Sci. USA 89, 5764±5768.to activate specific programs of adaptation appropriate
Hope, B.T., Nye, H.E., Kelz, M.B., Self, D.W., Iadarola, M.J., Naka-to the strength and time course of the stimulus. How-
beppu, Y., Duman, R.S., and Nestler, E.J. (1994). Neuron 13, 1235±ever, an unsolved problem with respect to downstream
1244.
effects of AP-1 proteins in thedorsal and ventral striatum
Jaber, M., Cador, M., Dumartin, B., Normand, E., Stinus, L., and
is that increased expression of AP-1 proteins, per se, Bloch, B. (1995). Neuroscience 64, 1041±1050.
or increased binding of AP-1 proteins to DNA as mea- Kombian, S.B., and Malenka, R.C. (1994). Nature 368, 242±246.
sured by gel shift assays does not necessarily indicate Konradi, C., Cole, R.L., and Hyman, S.E. (1994). J. Neurosci. 14,
increases in transcriptional activation. Thus, in trans- 5623±5634.
formed cell lines, phosphorylation of Ser-63 or Ser-73 Koob, G.F. (1996). Neuron 16, this issue.
within the c-Jun activation domain by Jun N-terminal Kosofsky, B.E., Genova, L.M., and Hyman, S.E. (1995). J. Comp.
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Several other alterations in cellular proteins caused by Xu, M., Moratalla, R., Gold, L.H., Hiroi, N., Koob, G.F., Graybiel, A.M.,
chronic cocaine administration are of particular interest and Tonegawa, S. (1994). Cell 79, 729±742.
because they also occur with chronic morphine adminis-
tration. Thus, for example, both cocaine and morphine
increase levels of tyrosine hydroxylase and decrease
levels of three neurofilament proteins in the VTA (re-
viewed by Self and Nestler, 1995). Understanding the
relationship of potential cytoskeletalchanges tophysiol-
ogy or behavior remains an important goal.
In addition to adaptations within the brain reward cir-
cuitry itself, drugs of abuse produce long-lived, posi-
tively biased, emotional memories that may be activated
by environmental or interoceptive cues. The mesoac-
cumbens DA circuitry appears to be involved in produc-
ing memories associated with reinforcement. It is an
open question whether cue-dependent drug craving ac-
tivates the mesoaccumbens DA pathway or whether DA
is involved in the production of such memories but not
in their subsequent recall. Evidence exists on both sides
of the issue (Brown and Fibiger, 1992, and references
therein). The resolution is important since development
of pharmacological blockers of cue-dependent craving,
which has been hypothesized (but not shown) to predis-
pose to relapse in humans, will obviously differ de-
pending on the receptors and circuits involved.
In summary, progress is being made in understanding
the molecular and cellular basis of addiction to cocaine
and amphetamine. While the identification of significant
molecular alterations and their relationship to behavior
are in their early days, the field is progressing rapidly
and should lead to the development of treatments for
cocaine and amphetamine addiction.
